1. Biochemistry and Chemical Biology
  2. Structural Biology and Molecular Biophysics

Receptor-mediated dimerization of JAK2 FERM domains is required for JAK2 activation

  1. Ryan D Ferrao
  2. Heidi Wallweber
  3. Patrick J Lupardus  Is a corresponding author
  1. Genentech Inc, United States
https://doi.org/10.7554/eLife.38089
Share this article
Cite this article
  1. Ryan D Ferrao
  2. Heidi Wallweber
  3. Patrick J Lupardus
(2018)
Receptor-mediated dimerization of JAK2 FERM domains is required for JAK2 activation
eLife 7:e38089.
https://doi.org/10.7554/eLife.38089
  2. Download BibTeX
  3. Download .RIS

Abstract

Cytokines and interferons initiate intracellular signaling via receptor dimerization and activation of Janus kinases (JAKs). How JAKs structurally respond to changes in receptor conformation induced by ligand binding is not known. Here we present two crystal structures of the human JAK2 FERM and SH2 domains bound to Leptin receptor (LEPR) and Erythropoietin receptor (EPOR), which identify a novel dimeric conformation for JAK2. This 2:2 JAK2/receptor dimer, observed in both structures, identifies a previously uncharacterized receptor interaction essential to dimer formation that is mediated by a membrane-proximal peptide motif called the 'switch' region. Mutation of the receptor switch region disrupts STAT phosphorylation but does not affect JAK2 binding, indicating that receptor-mediated formation of the JAK2 FERM dimer is required for kinase activation. These data uncover the structural and molecular basis for how a cytokine-bound active receptor dimer brings together two JAK2 molecules to stimulate JAK2 kinase activity.

Data availability

Coordinates and structure factors have been deposited into the RCSB database as PDB ID 6E2Q (JAK2/EPOR) and PDB ID 6E2P (JAK2/LEPR).

The following data sets were generated

Article and author information

Author details

  1. Ryan D Ferrao

    Department of Structural Biology, Genentech Inc, South San Francisco, United States
    Competing interests
    Ryan D Ferrao, employee of Genentech, Inc. during the period when this work was performed. The author declares they have no competing interests..

  2. Heidi Wallweber

    Department of Structural Biology, Genentech Inc, South San Francisco, United States
    Competing interests
    Heidi Wallweber, employee of Genentech, Inc. during the period when this work was performed. The author declares they have no competing interests..

  3. Patrick J Lupardus

    Department of Structural Biology, Genentech Inc, South San Francisco, United States
    For correspondence
    lupardus.patrick@gene.com
    Competing interests
    Patrick J Lupardus, employee of Genentech, Inc. during the period when this work was performed. The author declares they have no competing interests..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8662-074X

Funding

No external funding was received for this work.

Copyright

© 2018, Ferrao et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,514
    views
  • 755
    downloads
  • 48
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ryan D Ferrao
  2. Heidi Wallweber
  3. Patrick J Lupardus
(2018)
Receptor-mediated dimerization of JAK2 FERM domains is required for JAK2 activation
eLife 7:e38089.
https://doi.org/10.7554/eLife.38089

Share this article

https://doi.org/10.7554/eLife.38089

Categories and tags

Research organism

Further reading

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease

    On the role of VP3-PI3P interaction in birnavirus endosomal membrane targeting

    Flavia A Zanetti, Ignacio Fernandez ... Laura Ruth Delgui
    Research Article

    Birnaviruses are a group of double-stranded RNA (dsRNA) viruses infecting birds, fish, and insects. Early endosomes (EE) constitute the platform for viral replication. Here, we study the mechanism of birnaviral targeting of EE membranes. Using the Infectious Bursal Disease Virus (IBDV) as a model, we validate that the viral protein 3 (VP3) binds to phosphatidylinositol-3-phosphate (PI3P) present in EE membranes. We identify the domain of VP3 involved in PI3P-binding, named P2 and localized in the core of VP3, and establish the critical role of the arginine at position 200 (R200), conserved among all known birnaviruses. Mutating R200 abolishes viral replication. Moreover, we propose a two-stage modular mechanism for VP3 association with EE. Firstly, the carboxy-terminal region of VP3 adsorbs on the membrane, and then the VP3 core reinforces the membrane engagement by specifically binding PI3P through its P2 domain, additionally promoting PI3P accumulation.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease

    Cellular Energy Production: Mycofactocin and the mycobacterial electron transport chain

    Stephanie M Stuteley, Ghader Bashiri
    Insight

    In the bacterium M. smegmatis, an enzyme called MftG allows the cofactor mycofactocin to transfer electrons released during ethanol metabolism to the electron transport chain.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics

    A conformational fingerprint for amyloidogenic light chains

    Cristina Paissoni, Sarita Puri ... Carlo Camilloni
    Research Article

    Both immunoglobulin light-chain (LC) amyloidosis (AL) and multiple myeloma (MM) share the overproduction of a clonal LC. However, while LCs in MM remain soluble in circulation, AL LCs misfold into toxic-soluble species and amyloid fibrils that accumulate in organs, leading to distinct clinical manifestations. The significant sequence variability of LCs has hindered the understanding of the mechanisms driving LC aggregation. Nevertheless, emerging biochemical properties, including dimer stability, conformational dynamics, and proteolysis susceptibility, distinguish AL LCs from those in MM under native conditions. This study aimed to identify a2 conformational fingerprint distinguishing AL from MM LCs. Using small-angle X-ray scattering (SAXS) under native conditions, we analyzed four AL and two MM LCs. We observed that AL LCs exhibited a slightly larger radius of gyration and greater deviations from X-ray crystallography-determined or predicted structures, reflecting enhanced conformational dynamics. SAXS data, integrated with molecular dynamics simulations, revealed a conformational ensemble where LCs adopt multiple states, with variable and constant domains either bent or straight. AL LCs displayed a distinct, low-populated, straight conformation (termed H state), which maximized solvent accessibility at the interface between constant and variable domains. Hydrogen-deuterium exchange mass spectrometry experimentally validated this H state. These findings reconcile diverse experimental observations and provide a precise structural target for future drug design efforts.